🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
The goal of this study is to evaluate the safety of melphalan and autologou...
Status
Terminated
Location
Emory University Winship Cancer Institute
Start Date
2005-05
Trial ID
NCT00793650
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as carboplatin, thiotepa, and e...
Status
Completed
Location
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Start Date
2004-10
Trial ID
NCT00078988
Phase II trial to study the effectiveness of combination chemotherapy and p...
Status
Terminated
Location
Gynecologic Oncology Group
Start Date
1999-11
Trial ID
NCT00004221
Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Status
Completed
Location
Stanford University Medical Center
Start Date
2009-08
Trial ID
NCT00490529
This is a standard of care document, outlining the therapy for children wit...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-03-28
Trial ID
NCT01526603
The purpose of this trial was to evaluate efficacy and safety of adding Rit...
Status
Completed
Location
Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo
Start Date
2002-06
Trial ID
NCT00556127
To determine the safety of the approach of giving RUXOLITINIB before and af...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02469974
Treatments Being Tested
* Study No.: KSPNO-S-081 Reduced-dose Craniospinal Radiotherapy Followed by...
Status
Unknown
Location
Samsung Medical Center
Start Date
2005-09
Trial ID
NCT00798811
Thalidomide-Dexamethasone (TD) is a standard induction therapy for Multiple...
Status
Unknown
Location
AOU di Bologna Policlinico S.Orsola-Malpighi, UO di Ematologia
Start Date
2006-05
Trial ID
NCT01134484